Feds Propose Rule to Help Employers Expand Fertility Benefit Coverage

Why It Matters

Expanding employer‑provided fertility coverage could improve talent retention and address the nation’s declining birth rate, while giving companies a clearer regulatory framework for offering high‑cost reproductive care.

Key Takeaways

• $120,000 lifetime fertility benefit cap, inflation‑indexed from 2028.
• Benefits classified as “limited excepted,” exempt from ACA mandates.
• Only 42% of employers currently offer any fertility benefits.
• Rule targets declining U.S. birth rate and 1‑in‑5 infertility prevalence.

Pulse Analysis

The rising cost of assisted reproductive technologies has turned fertility care into a workplace benefits flashpoint. IVF cycles typically run $12,000 to $25,000, a price many employees cannot absorb without employer support. Earlier in 2025, the Trump administration’s executive order highlighted this financial strain, prompting guidance that allowed standalone fertility benefits. By reclassifying such benefits as limited excepted, the new rule aligns them with dental and vision plans, creating a tax‑advantaged pathway that sidesteps ACA affordability and essential‑health‑benefits tests. This regulatory tweak lowers administrative friction for HR teams and opens the door for broader adoption across mid‑size firms.

From a business perspective, the proposal offers a strategic lever for talent acquisition and retention, especially in competitive sectors like technology and professional services where high‑skill workers value comprehensive health packages. The $120,000 lifetime cap, indexed for inflation, provides a meaningful safety net without imposing unlimited liability on employers. Moreover, the exemption from ACA mandates could reduce compliance costs, making fertility benefits a more attractive line‑item in total compensation budgets. Companies that act early may also benefit from positive employer branding, positioning themselves as family‑friendly workplaces amid a demographic slowdown.

Nevertheless, the rule faces practical hurdles. Smaller firms may lack the scale to administer separate excepted benefits, and self‑insured plans could encounter funding challenges. Critics argue that a capped benefit may still leave lower‑income workers under‑served, especially given that only 42% of employers currently offer any fertility coverage. The 60‑day public comment window will likely surface concerns about equity, cost‑sharing structures, and integration with existing health reimbursement arrangements. As policymakers and industry groups debate these issues, the final rule could set a precedent for how the U.S. addresses reproductive health in the broader benefits landscape.